SLE/Fibromyalgia Flashcards
Autoimmune Disease
Pathophysiology
The body’s immune system attacks healthy cells; cannot distinguish between healthy and unhealthy cells; leads to an inflammatory state
Autoimmune Disease
Risk Factors and most common diseases
Environmental (smoking, diet, stress, pollution, infectious)
Genetic
Rheumatoid arthritis, Lupus, Celiac Disease, Sjogren’s syndrome, Multiple Sclerosis, Polymyalgia Rheumatica, Ankylosing Spondylitis, Diabetes Mellitus Type 1, Alopecia Areata, Vasculitis, Temporal Arteritis, Chron’s, Scleroderma, Hashimoto’s Thyroiditis
autoimmune disorders
challenginhg to diagnose
Symptoms: fatigue, malaise, activity intolerance, pain, low grade fever
Usually requires evaluation by multiple specialists of a long period of time
Goes in and out of stages flare up-active-remission
Not uncommon to have two or more autoimmune problems
Systemic Lupus Erythematosus (SLE)
General/presentation
Autoimmune disorder associated with inflammation, + ANA, multiple organ involvement
Presentation: Fever, anorexia, malaise, weight loss, malar rash, arthralgias
Work up: CBC (anemia, thrombocytopenia), CMP, UA (proteinuria), ESR, serum complement (low C3 or C4); ANA +
Diagnosis: meet 4/11 criteria “ RASHNIA4”
SLE
RASHNIA4
Diagnosis: meet 4/11 criteria “ RASHNIA4”
R: renal disease ( + proteinuria)
A: arthralgias
S: serositis ( pleuritis, pericarditis)
H: hematologic disorder ( anemia, thrombocytopenia)
N: neurologic disorder (seizure, psychosis)
I: immunologic abnormalities
A: antinuclear antibodies (ANA)
4 types of rashes 1- malar “butterfly” 2-discoid (chronic, scarring) 3-photosensitivity 4-oral ulcers
SLE
Pathophysiology
Multisystem inflammatory autoimmune disease
More common in females than males by 9:1, more common black women vs white
Peak age of Dx is 9-15 yrs
Susceptible individual has apoptosis event
Due to genetics, has defective clearance
Immune response leads to immune complexes
Autoantibodies against nuclear antigens
Complement activation, levels reduced
Neutrophil extracellular traps (NETs)
Release of interferon-alpha (IFN a)
Tissue and organ damage
Can be drug-induced! ( hydralazine, procainamide, INH, Quinidine)
Discoid Lupus Erythematosus
Subacute cutaneous lupus erythematosus
SLE
labs and imaging
Physical exam findings as mentioned
Labs:
CBC (anemia, thrombocytopenia)
CMP
UA (proteinuria)
ESR
ANA + ( ANA is highly sensitive but nonspecific- if + check antibodies)
Antibodies: antiphospholipid, anti-smith (Lupus), anti-dsDNA (nephritis), anti-histone (drug-related lupus)
serum complement (low C3 or C4)
Imaging: (?)
Cxray ( rule out effusion/pulm involvement)
Ecg/echocardiogram (rule out cardiac involvement)
+ ANA means autoantibodies are present thus your immune system is attacking itself
+ anti-DS DNA and anti-smith are specific to SLE
ANA can be positive in CREST, Sjogren’s, myositis, scleroderma
can be used if in Rheum, notice anti Smith and anti ds DNA are most specific
SLE
Tx
pharm and non-pharm
Close monitoring
Goal is to improve/maintain organ function and prevent permanent organ injury
Pharmacotherapy : (dose on disease activity)
Hydroxychloroquine (Plaquenil) 1st line
Corticosteroids for acute flare
NSAIDS- treat symptoms not dz
Iv cyclophosphamide for life-threatening cerebritis or nephritis followed by oral mycophenolate mofetil
Non-Pharmacologic:
Avoid sunlight/high sunscreen factor
Counseling support
Healthy diet and exercise
Hydroxychloroquine-annual eye exam
Methotrexate: CBC, CMP q 3 months
Glucocorticoids: FLP, CMP, DEXA annually
SLE complication
Lupus Nephritis
Labs, dx, tx
Check UA and urine micro ( + hematuria, casts, and proteinuria)
Will need kidney biopsy
Treatment: IV cyclophosphamide followed by po mycophenolate mofetil
SLE
Monitoring Lupus
Pregnancy counseling
Labs: CMC, UA, BMP, ESR ( +/- antibodies) q 6months
Annual eye exam if on HCQ
Screening for hyperlipidemia, diabetes and osteoporosis if on steroids
Current Vaccines